Age (y) | 66.94±12.32 | 61.01±16.90 | 0.044 |
Male sex | 61 (56.48) | 43 (68.25) | 0.146 |
African American | 63 (58.33) | 41 (65.08) | 0.331 |
Body mass index (kg/m2) | 26.77 [23.09–31.35] | 25.71 [21.15–30.30] | 0.221 |
Diabetes mellitus | 53 (49.07) | 11 (17.46) | 0.001 |
Hemoglobin A1c (%) | 6.05 [5.40–7.33] | 5.35 [5.00–5.80] | <0.001 |
Pitt Bacteremia Score | 4.00 [2.75–7.25] | 3.00 [2.0–6.00] | 0.012 |
Charlson Comorbidity Index | 5.54±2.45 | 4.62±2.67 | 0.201 |
Placed on tube feeds | 66 (61) | 34 (54) | 0.361 |
Received corticosteroids | 43 (39.81) | 18 (28.57) | 0.139 |
Total hydrocortisone equivalent dose (mg) | 0 [0–412.50] | 0 [0–275.00] | 0.211 |
Total insulin requirements (units) | 5.5 [0–59.25] | 0 [0–0] | <0.001 |
Causative organisms of bacteremia, n (%) | | | 0.336 |
Gram negative | 54 (50.00) | 28 (44.44) | |
Gram positive | 46 (42.59) | 26 (41.27) | |
Polymicrobial | 8 (7.41) | 9 (14.29) | |
Source of bacteremia, n (%) | | | 0.744 |
Urinary | 23 (21.30) | 15 (23.81) | |
Respiratory | 14 (12.96) | 9 (14.29) | |
Central venous catheter | 11 (10.19) | 4 (6.35) | |
Skin and soft tissue | 8 (7.41) | 7 (11.11) | |
Multiple | 11 (10.19) | 9 (14.29) | |
Other | 41 (37.96) | 19 (30.16) | |